Therapeutic Area | MeSH |
---|---|
mental disorders | D001523 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
LUVOX | ANI Pharmaceuticals | N-021519 RX | 2007-12-20 | 3 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
fluvoxamine maleate | ANDA | 2025-03-05 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Drug common name | Fluvoxamine |
INN | fluvoxamine |
Description | Fluvoxamine is an oxime O-ether that is benzene substituted by a (1E)-N-(2-aminoethoxy)-5-methoxypentanimidoyl group at position 1 and a trifluoromethyl group at position 4. It is a selective serotonin reuptake inhibitor that is used for the treatment of obsessive-compulsive disorder. It has a role as an antidepressant, a serotonin uptake inhibitor and an anxiolytic drug. It is a 5-methoxyvalerophenone O-(2-aminoethyl)oxime and a member of (trifluoromethyl)benzenes. It is functionally related to a (trifluoromethyl)benzene. |
Classification | Small molecule |
Drug class | Selective serotonin reuptake inhibitor (SSRI) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | COCCCC/C(=N\OCCN)c1ccc(C(F)(F)F)cc1 |
PDB | — |
CAS-ID | 54739-18-3 |
RxCUI | — |
ChEMBL ID | CHEMBL814 |
ChEBI ID | 5138 |
PubChem CID | 5324346 |
DrugBank | DB00176 |
UNII ID | O4L1XPO44W (ChemIDplus, GSRS) |